204 related articles for article (PubMed ID: 25410057)
1. Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I.
Heppner JM; Zaucke F; Clarke LA
Mol Genet Metab; 2015 Feb; 114(2):146-55. PubMed ID: 25410057
[TBL] [Abstract][Full Text] [Related]
2. Proteoglycans and diseases of soft tissues.
Halper J
Adv Exp Med Biol; 2014; 802():49-58. PubMed ID: 24443020
[TBL] [Abstract][Full Text] [Related]
3. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis.
Ameye L; Aria D; Jepsen K; Oldberg A; Xu T; Young MF
FASEB J; 2002 May; 16(7):673-80. PubMed ID: 11978731
[TBL] [Abstract][Full Text] [Related]
4. Characterization of joint disease in mucopolysaccharidosis type I mice.
de Oliveira PG; Baldo G; Mayer FQ; Martinelli B; Meurer L; Giugliani R; Matte U; Xavier RM
Int J Exp Pathol; 2013 Oct; 94(5):305-11. PubMed ID: 23786352
[TBL] [Abstract][Full Text] [Related]
5. Small leucine rich repeat proteoglycans (SLRPs) in the human sclera: identification of abundant levels of PRELP.
Johnson JM; Young TL; Rada JA
Mol Vis; 2006 Sep; 12():1057-66. PubMed ID: 17093390
[TBL] [Abstract][Full Text] [Related]
6. Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis.
Embree MC; Kilts TM; Ono M; Inkson CA; Syed-Picard F; Karsdal MA; Oldberg A; Bi Y; Young MF
Am J Pathol; 2010 Feb; 176(2):812-26. PubMed ID: 20035055
[TBL] [Abstract][Full Text] [Related]
7. Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.
Kingma SDK; Wagemans T; IJlst L; Bronckers ALJJ; van Kuppevelt TH; Everts V; Wijburg FA; van Vlies N
Bone; 2016 Jul; 88():92-100. PubMed ID: 27105565
[TBL] [Abstract][Full Text] [Related]
8. Colocalization of the collagen-binding proteoglycans decorin, biglycan, fibromodulin and lumican with different cells in human gingiva.
Alimohamad H; Habijanac T; Larjava H; Häkkinen L
J Periodontal Res; 2005 Feb; 40(1):73-86. PubMed ID: 15613083
[TBL] [Abstract][Full Text] [Related]
9. Sustained expression of proteoglycans and collagen type III/type I ratio in a calcified tendinopathy model.
Lui PP; Chan LS; Lee YW; Fu SC; Chan KM
Rheumatology (Oxford); 2010 Feb; 49(2):231-9. PubMed ID: 19955224
[TBL] [Abstract][Full Text] [Related]
10. Biglycan and fibromodulin fragmentation correlates with temporal and spatial annular remodelling in experimentally injured ovine intervertebral discs.
Melrose J; Smith SM; Fuller ES; Young AA; Roughley PJ; Dart A; Little CB
Eur Spine J; 2007 Dec; 16(12):2193-205. PubMed ID: 17899219
[TBL] [Abstract][Full Text] [Related]
11. Ectopic chondro-ossification and erroneous extracellular matrix deposition in a tendon window injury model.
Lui PP; Cheuk YC; Lee YW; Chan KM
J Orthop Res; 2012 Jan; 30(1):37-46. PubMed ID: 21761446
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor deficient mice: an immunohistochemical study.
Ström A; Ahlqvist E; Franzén A; Heinegård D; Hultgårdh-Nilsson A
Histol Histopathol; 2004 Apr; 19(2):337-47. PubMed ID: 15024695
[TBL] [Abstract][Full Text] [Related]
13. Accelerated osteoarthritis in the temporomandibular joint of biglycan/fibromodulin double-deficient mice.
Wadhwa S; Embree MC; Kilts T; Young MF; Ameye LG
Osteoarthritis Cartilage; 2005 Sep; 13(9):817-27. PubMed ID: 16006154
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator.
Clarke LA
Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v13-8. PubMed ID: 22210665
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Matrix Mediates BMP-2 in a Model of Temporomandibular Joint Osteoarthritis.
Shirakura M; Kram V; Robinson J; Sikka S; Kilts TM; Wadhwa S; Young MF
Cells Tissues Organs; 2017; 204(2):84-92. PubMed ID: 28419987
[TBL] [Abstract][Full Text] [Related]
16. Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar.
Honardoust D; Varkey M; Hori K; Ding J; Shankowsky HA; Tredget EE
Wound Repair Regen; 2011; 19(3):368-78. PubMed ID: 21518082
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the expression pattern of five genes of the family of small leucine-rich proteoglycans during mouse development.
Wilda M; Bächner D; Just W; Geerkens C; Kraus P; Vogel W; Hameister H
J Bone Miner Res; 2000 Nov; 15(11):2187-96. PubMed ID: 11092399
[TBL] [Abstract][Full Text] [Related]
18. Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation.
Opoka-Winiarska V; Jurecka A; Emeryk A; Tylki-Szymańska A
Osteoarthritis Cartilage; 2013 Dec; 21(12):1813-23. PubMed ID: 23954699
[TBL] [Abstract][Full Text] [Related]
19. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.
Sztrolovics R; White RJ; Poole AR; Mort JS; Roughley PJ
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):571-7. PubMed ID: 10215595
[TBL] [Abstract][Full Text] [Related]
20. Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis.
Young AA; Smith MM; Smith SM; Cake MA; Ghosh P; Read RA; Melrose J; Sonnabend DH; Roughley PJ; Little CB
Arthritis Res Ther; 2005; 7(4):R852-61. PubMed ID: 15987487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
